$IMLFF Inmed Pharmaceuticals CEO Eric Adams, a veteran of the biopharma sector, says the marijuana plant has dozens of cannabinoids other than THC and CBD. He's working on treatments that could include a drug for epidermolysis bullosa simplex (EBS), a devastating skin disease, and glaucoma.

http://www.bnn.ca/video/inmed-pharmaceuticals...hc~1020413